$8.51
0.384.67%
Pre-Market: 7:49 PM EDT
Comments
Loading...
Latest Arvinas Stock News | NASDAQ:ARVN | Benzinga
Get the latest news on Arvinas stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Arvinas performance
Categories: All
Friday, March 14, 2025
Thursday, March 13, 2025
Wednesday, March 12, 2025
Tuesday, March 11, 2025
- Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial
- Crude Oil Gains 1%; Ciena Earnings Top Views
- HC Wainwright & Co. Reiterates Buy on Arvinas...
- US Stocks Mixed; Kohl's Shares Plunge After Q4 Results
- Arvinas shares are trading lower after the co...
- Arvinas And Pfizer Announced Topline Results ...
Friday, March 07, 2025
Wednesday, February 12, 2025
- These Analysts Revise Their Forecasts On Arvinas After Q4 Results
- Oppenheimer Maintains Outperform on Arvinas, ...
- BMO Capital Reiterates Outperform on Arvinas,...
- Guggenheim Reiterates Buy on Arvinas, Maintai...
- Snowflake To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday
- Stifel Maintains Buy on Arvinas, Lowers Price...